The mechanisms of resistance to antimalarial drugs in Plasmodium falciparum

Fundamental and Clinical Pharmacology

Volumn 17, Issue 2, 2003, Pages 147-153

  Le Bras, Jacques ^a   Durand, Rémy ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Drugs; Genetics; Plasmodium; Resistance

Indexed keywords

AMODIAQUINE; ARTEMETHER; ATOVAQUONE; BENFLUMETOL; CHLOROQUINE; CYCLOGUANIL; HALOFANTRINE; MEFLOQUINE; PROGUANIL; PYRIMETHAMINE; QUININE; SULFADOXINE;

ARTICLE; CHROMOSOME MUTATION; DRUG EFFECT; DRUG MECHANISM; DRUG MONITORING; HUMAN; MALARIA FALCIPARUM; MEMBRANE PERMEABILITY; MOLECULAR CLONING; MULTIDRUG RESISTANCE; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; PROPHYLAXIS; PROSPECTIVE STUDY; STRAIN DIFFERENCE;

AFRICA; ANIMALS; ANTIMALARIALS; ANTIMETABOLITES; CHLOROGUANIDE; CHLOROQUINE; DRUG RESISTANCE; DRUG RESISTANCE, MULTIPLE; HUMANS; MALARIA, FALCIPARUM; PLASMODIUM FALCIPARUM; PYRIMETHAMINE; TRIAZINES;

EID: 0037396367     PISSN: 07673981     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1472-8206.2003.00164.x     Document Type: Article

References (26)

1. Greenwood B., Mutabingwa T. Malaria in 2002. Nature (2002) 415 670-672.
2. Trape J.F., Pison G., Preziosi M.P. et al. Impact of chloroquine resistance on malaria mortality. C. R. Acad. Sci. III (1998) 32 689-697.
3. Ohrt C., Mirabelli. Primdahl L., Karnasuta C., Chantakulkij S., Kain K.C. Distinguishing Plasmodium falciparum treatment failures from reinfections by restriction fragment length polymorphism and polymerase chain reaction genotyping. Am. J. Trop. Med. Hyg. (1997) 57 430-437.
4. Reed M.B., Saliba K.J., Caruana S.R., Kirk K., Cowman A. Pgh1 modulates sensitivity and resistance to multiple antimalarials in Plasmodium falciparum. Nature (2000) 403 906-909.
5. Bray P.G., Mungthin M., Ridley R.G., Ward S.A. Access to hematin: the basis of chloroquine resistance. Mol. Pharmacol. (1998) 54 170-179.
6. Wellems T., Plowe C.V. Chloroquine-resistant malaria. J. Infect. Dis. (2001) 184 770-776.
7. Djimde A., Doumbo O.K., Cortese J.F. et al. A molecular marker for chloroquine-resistant falciparum malaria. N. Engl. J. Med. (2001) 344 257-263.
8. Durand R., Jafari S., Vauzelle J., Delabre J.F., Jesic Z., Le Bras J. Analysis of pfcrt point mutations and chloroquine susceptibility in isolates of Plasmodium falciparum. Mol. Biochem. Parasitol. (2001) 114 95-102.
9. Basco L.K., Eldin de Pécoulas P., Wilson C., Le Bras J., Mazabraud A. Point mutation in the dihydrofolate reductase gene as the molecular basis for pyrimethamine and cycloguanil resistance in Plasmodium falciparum. Mol. Biochem. Parasitol. (1995) 69 135-138.
10. Nzila-Mouda A., Mberu E.K., Sibley C.H., Plowe C.V., Winstanley P.A., Watkins W.M. Kenyan P. falciparum field isolates: correlation between pyrimethamine and chlorcycloguanil activity in vitro and point mutations in the dihydrofolate reductase domain. Antimicrob. Agents Chemother. (1998) 42 164-169.
11. Sirawaraporn W., Sathitkul S., Sirawaraporn R., Yuthavong Y., Santi D.V. Antifolate-resistant mutants of Plasmodium falciparum dihydrofolate reductase. Proc. Nat. Acad. Sci. USA (1997) 94 1124-1129.
12. Durand R., Ramiliarisoa O., Sécardin Y., Eldin de Pécoulas P., Basco L.K., Le Bras J. DHFR gene point mutation as a predictor of Plasmodium falciparum resistance to cycloguanil in malaria cases from Africa imported to France. Trans. R. Soc. Trop. Med. Hyg. (1997) 91 460-461.
13. Parzy D., Doerig C., Pradines B., Rico A., Fusai T., Doury J.C. Proguanil resistance in Plasmodium falciparum African isolates: assessment by mutation-specific polymerase chain reaction and in vitro susceptibility testing. Am. J. Trop. Med. Hyg. (1997) 57 646-650.
14. Durand R., Jafari S., Bouchaud O., Ralaimazava P., Keundjian A., Le Bras J. Plasmodium falciparum: pfcrt and DHFR mutations are associated with chloroquine plus proguanil prophylaxis failures in travelers. J. Infect. Dis. (2001) 184 1633-1634.
15. Basco L.K., Tahar R., Ringwald P. Molecular basis of in vivo resistance to sulfadoxine-pyrimethamine in African adult patients infected with P. falciparum malaria parasites. Antimicrob. Agents Chemother. (1998) 42 1811-1814.
16. Curtis J., Duraisingh M.T., Warhurst D.C. In vivo selection for a specific genotype of dihydropteroate synthetase of P. falciparum by pyrimethamine-sulfadoxine but not by chlorproguanil-dapsone treatment. J. Infect. Dis. (1998) 177 1429-1433.
17. Wang P., Read M., Sims P.F., Hyde J.E. Sulfadoxine resistance in the human parasite P. falciparum is determined by mutations in dihydropteroate synthetase and an additional factor associated with folate utilisation. Mol. Microbiol. (1997) 23 979-986.
18. Wang P., Lee C.S., Bayoumi R. et al. Resistance to antifolates in P. falciparum monitored by sequence analysis of dihydropteroate synthetase and dihydrofolate reductase alleles in a large number of field samples of diverse origins. Mol. Biochem. Parasitol. (1997) 89 161-177.
19. Kublin J.G., Witzig R.S., Shankar A.H. et al. Molecular assays for surveillance of antifolate-resistant malaria. Lancet (1998) 35 1629-1630.
20. Srivastava I., Rottenberg H., Vaidya A, Atovaquone, a broad spectrum antiparasitic drug collapses mitochondrial membrane potential in malaria parasites. J. Biol. Chem. (1997) 272 3961-3966.
21. White N.J. Why is it that antimalarial drug treatments do not always work? Ann. Trop. Med. Parasitol. (1998) 92 449-458.
22. Oduola A.M.J., Milhous W.K., Walker O., Desjardins R.E. Reduced in vitro susceptibility to mefloquine in West African isolates of P. falciparum. Lancet (1987) 2 1304-1305.
23. Simon F., Le Bras J., Gaudebout C., Girard P.M. Reduced sensitivity of P. falciparum to mefloquine in West Africa. Lancet (1988) 1 467-468.
24. Basco L.K., Le Bras J. In vitro activity of halofantrine and its relationship to other standard antimalarials against African isolates and clones of P. falciparum. Am. J. Trop. Med. Hyg. (1992) 47 521-527.
25. Olliaro P., Nevill C., Le Bras J., Ringwald P., Mussano P., Garner P., Brasseur P. Amodiaquine treatment in uncomplicated malaria. A systematic review of published and unpublished data. Lancet (1996) 348 1196-1201.
26. Le Bras J., Durand R., di Piazza J.P., Pradines B., Longuet C., Parzy D. Prise en compte des disparités de résistance de P. falciparum en Afrique dans la décision chimioprophylactique. Presse Med. (1998) 27 1419-1423.